SPONSOR
University of Ulm
Total Trials
7
Recruiting
7
Phases
Phase 2
Conditions studied: Gestational Diabetes Mellitus (GDM)Chronic Inflammatory Demyelinating PolyneuropathyAmyotrophic Lateral Sclerosis (ALS)COVID-19Critical IllnessHypercytokinemiaLung FibrosisCIDPBCR-ABL1-Negative Myeloid NeoplasmsPancreas Adenocarcinoma
University of Ulm is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Gestational Diabetes Mellitus (GDM), Chronic Inflammatory Demyelinating Polyneuropathy, Amyotrophic Lateral Sclerosis (ALS), COVID-19.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Ulm
How many clinical trials has University of Ulm sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by University of Ulm, of which 7 are actively recruiting participants. These trials cover conditions including Gestational Diabetes Mellitus (GDM), Chronic Inflammatory Demyelinating Polyneuropathy, Amyotrophic Lateral Sclerosis (ALS). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Ulm research focus on?
University of Ulm clinical trials span Gestational Diabetes Mellitus (GDM), Chronic Inflammatory Demyelinating Polyneuropathy, Amyotrophic Lateral Sclerosis (ALS), COVID-19, Critical Illness, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Ulm clinical trial?
To participate in a University of Ulm trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Ulm trials with current recruitment status updated daily.
Clinical Trials by University of Ulm
NCT07436195
Recruiting
Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabetes Through Cell-free DNA
Gestational Diabetes Mellitus (GDM)
NCT07154524
Recruiting
Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Chronic Inflammatory Demyelinating Polyneuropathy
NCT06877143
Recruiting
Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis
Amyotrophic Lateral Sclerosis (ALS)
NCT05191381
Recruiting
Immune Modulation by Exosomes in COVID-19
COVID-19
NCT04881682 Phase 2
Recruiting
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
CIDP
NCT03125707
Recruiting
German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm)
BCR-ABL1-Negative Myeloid Neoplasms
NCT04099134
Recruiting
PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma
Pancreas Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology